News

Symmetry and DePuy will enter into a supply agreement which will require DePuy to make minimum purchases from the New Bedford facility for a four year period following

Baxter and Pfizer signed marketing, supply and manufacturing agreement for Gelfoam plus hemostasis kit. Under the terms of the agreement, Baxter is the exclusive distributor of Gelfoam plus

Bard’s Davol subsidiary, located in Cranston, Rhode Island, will begin marketing the line immediately. The Sepramesh IP product incorporates a polypropylene mesh with a layer of Sepra material

The oxycodone, administered as a single transdermal application, was safe with no adverse events reported. Oxycodone was detected in the subjects for at least 48 hours. The results

Under the collaboration, Oxford Genome Sciences (OGeS) and Amgen will generate fully human antibodies using Amgen’s XenoMouse technology, which was acquired through its acquisition of Abgenix. These antibodies

Under the terms of the agreement, the two commercial partners DNage and Solvay Pharmaceuticals will collaborate with eight top class academic groups to embark on a four year

The observed safety profile was consistent with earlier findings in clinical studies that led to the approval of bosentan (Tracleer 125mg bid) in pulmonary arterial hypertension (PAH). The

The acquisition is said to strengthen Sandvik’s position in the strategically important and rapidly expanding medical segment. The acquisition will be consolidated from 14 December 2007. Peter Gossas,

This Phase I study was a randomized, double-blind, placebo-controlled trial in healthy adult volunteers to assess the safety, tolerability, and pharmacokinetics of inhaled ALN-RSV01 administered via nebulizer. All